更多...
收起
This gene encodes a nuclear-localized E3 ubiquitin ligase. The encoded protein can promote tumor formation by targeting tumor suppressor proteins, such as p53, for proteasomal degradation. This gene is itself transcriptionally-regulated by p53. Overexpression or amplification of this locus is detected in a variety of different cancers. There is a pseudogene for this gene on chromosome 2. Alternative splicing results in a multitude of transcript variants, many of which may be expressed only in tumor cells. [provided by RefSeq, Jun 2013]
[中文简述(自动翻译):]  该基因编码一个核本地化的E3泛素连接酶。所编码的蛋白质可通过靶向肿瘤抑制蛋白,如p53,对蛋白酶体降解促进肿瘤的形成。该基因是由p53基因本身转录上调。过表达或该基因座的扩增在各种不同的癌症的检测。有这个基因在染色体2.选择性剪接的结果在转录变异体,其中有许多可能只在肿瘤细胞中表达的大量假基因。 [由RefSeq的,2013年6月提供]
MDM2基因(以及对应的蛋白质)的细胞分布位置:
MDM2基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Mammary Neoplasms | 0.247956418 | 24 | 2 | BeFree_CTD_human_GAD_LHGDN_RGD |
Li-Fraumeni Syndrome | 0.133897074 | 15 | 2 | BeFree_GAD_LHGDN_ORPHANET |
melanoma | 0.13198705 | 19 | 3 | BeFree_CTD_human_GAD |
Prostatic Neoplasms | 0.128001298 | 6 | 0 | BeFree_CTD_human_GAD_LHGDN |
Liposarcoma, Dedifferentiated | 0.127600372 | 28 | 0 | BeFree_ORPHANET |
Non-Small Cell Lung Carcinoma | 0.126514605 | 25 | 0 | BeFree_CTD_human |
Liposarcoma, well differentiated | 0.125157396 | 19 | 0 | BeFree_ORPHANET |
Neoplastic Cell Transformation | 0.122367032 | 2 | 0 | CTD_human_GAD |
HIV Infections | 0.120814326 | 4 | 0 | BeFree_CTD_human |
Precancerous Conditions | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Male infertility | 0.120271442 | 1 | 0 | BeFree_CTD_human |
Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO | 0.12 | 0 | 1 | CLINVAR |
Transient Ischemic Attack | 0.08 | 1 | 0 | RGD |
Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
Fetal Growth Retardation | 0.08 | 1 | 0 | RGD |
Hypothermia, natural | 0.08 | 1 | 0 | RGD |
Ichthyoses | 0.08 | 1 | 0 | RGD |
Intermittent Claudication | 0.08 | 1 | 0 | RGD |
Liver diseases | 0.08 | 1 | 0 | RGD |
Myocardial Reperfusion Injury | 0.08 | 1 | 0 | RGD |
Pancreatitis | 0.08 | 1 | 0 | RGD |
Priapism | 0.08 | 1 | 0 | RGD |
Post-Traumatic Stress Disorder | 0.08 | 1 | 0 | RGD |
Malignant neoplasm of breast | 0.05931642 | 83 | 7 | BeFree_GAD |
Malignant neoplasm of lung | 0.042291526 | 29 | 0 | BeFree_GAD |
Sarcoma | 0.038322962 | 93 | 2 | BeFree_LHGDN |
Carcinogenesis | 0.035287443 | 130 | 1 | BeFree |
Lung Neoplasms | 0.030338984 | 15 | 0 | BeFree_GAD_LHGDN |
Squamous cell carcinoma | 0.030332933 | 34 | 2 | BeFree_GAD_LHGDN |
liposarcoma | 0.024207984 | 43 | 0 | BeFree_LHGDN |
Liver carcinoma | 0.021507378 | 33 | 2 | BeFree_GAD_LHGDN |
Glioblastoma | 0.021235936 | 33 | 0 | BeFree_GAD_LHGDN |
Breast Carcinoma | 0.020901024 | 77 | 7 | BeFree |
Chronic Lymphocytic Leukemia | 0.019445464 | 19 | 2 | BeFree_GAD_LHGDN |
Malignant neoplasm of prostate | 0.018154268 | 34 | 0 | BeFree_GAD |
Malignant neoplasm of urinary bladder | 0.017730936 | 15 | 0 | BeFree_GAD |
Colorectal Cancer | 0.017263997 | 22 | 2 | BeFree_GAD |
Neuroblastoma | 0.016254175 | 25 | 0 | BeFree_GAD |
Glioma | 0.01596892 | 22 | 2 | BeFree_GAD_LHGDN |
Colorectal Neoplasms | 0.015902907 | 6 | 0 | BeFree_GAD_LHGDN |
Neoplasm Metastasis | 0.015144663 | 30 | 0 | BeFree_GAD_LHGDN |
Bladder Neoplasm | 0.014078759 | 7 | 0 | BeFree_GAD_LHGDN |
Rhabdomyosarcoma | 0.012516121 | 17 | 0 | BeFree_LHGDN |
Brain Neoplasms | 0.012378044 | 6 | 0 | BeFree_GAD |
Renal Cell Carcinoma | 0.012158802 | 17 | 0 | BeFree_GAD_LHGDN |
Osteosarcoma | 0.012138939 | 36 | 3 | BeFree_GAD |
leukemia | 0.011887361 | 17 | 0 | BeFree_GAD_LHGDN |
Mouth Neoplasms | 0.01183516 | 5 | 0 | GAD |
Leukemia, Myelocytic, Acute | 0.011791553 | 27 | 1 | BeFree_GAD |
Endometrial Neoplasms | 0.010182764 | 3 | 0 | GAD_LHGDN |
Adenocarcinoma | 0.009901391 | 11 | 3 | BeFree_GAD_LHGDN |
Skin Neoplasms | 0.009468128 | 4 | 0 | GAD |
Papillomavirus Infections | 0.009468128 | 4 | 0 | GAD |
Lymphoma | 0.009434452 | 18 | 0 | BeFree_GAD_LHGDN |
Prostate carcinoma | 0.008143256 | 30 | 0 | BeFree |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.008077243 | 12 | 0 | BeFree_GAD_LHGDN |
Pancreatic Neoplasm | 0.008001298 | 4 | 0 | BeFree_GAD_LHGDN |
Liver neoplasms | 0.007915422 | 6 | 0 | BeFree_GAD |
Tumor Progression | 0.007871814 | 29 | 0 | BeFree |
Malignant neoplasm of stomach | 0.007795869 | 21 | 4 | BeFree_GAD |
Retinoblastoma | 0.007795869 | 20 | 0 | BeFree_GAD |
Stomach Neoplasms | 0.007729856 | 3 | 0 | BeFree_GAD_LHGDN |
Uterine Cervical Neoplasm | 0.007101096 | 3 | 0 | GAD |
Malignant neoplasm of ovary | 0.006981544 | 17 | 1 | BeFree_GAD |
Carcinoma of lung | 0.006514605 | 24 | 0 | BeFree |
Central neuroblastoma | 0.006514605 | 24 | 0 | BeFree |
Endometrial Carcinoma | 0.00643866 | 15 | 3 | BeFree_GAD |
Osteosarcoma of bone | 0.006243163 | 23 | 2 | BeFree |
Carcinoma, Transitional Cell | 0.00617715 | 5 | 0 | BeFree_GAD_LHGDN |
B-Cell Lymphomas | 0.00617715 | 6 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of esophagus | 0.006091273 | 6 | 0 | BeFree_GAD |
Hodgkin Disease | 0.005991584 | 4 | 0 | BeFree_LHGDN |
Thyroid Neoplasm | 0.005720142 | 3 | 0 | BeFree_LHGDN |
Colorectal Carcinoma | 0.005700279 | 21 | 2 | BeFree |
Stomach Carcinoma | 0.005700279 | 21 | 4 | BeFree |
Rheumatoid Arthritis | 0.005634266 | 3 | 1 | BeFree_GAD_LHGDN |
Myeloid Leukemia | 0.005276948 | 4 | 0 | BeFree_GAD |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.004895885 | 9 | 0 | BeFree_LHGDN |
Lipoma | 0.004885954 | 18 | 0 | BeFree |
Ovarian Carcinoma | 0.004885954 | 18 | 1 | BeFree |
Head and Neck Neoplasms | 0.004734064 | 2 | 0 | GAD |
Lymphoma, Non-Hodgkin | 0.004734064 | 2 | 0 | GAD |
Nasopharyngeal Neoplasms | 0.004734064 | 2 | 0 | GAD |
leiomyosarcoma | 0.004624443 | 8 | 0 | BeFree_LHGDN |
Mixed Salivary Gland Tumor | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Malignant neoplasm of endometrium | 0.003800186 | 14 | 3 | BeFree |
Carcinoma of bladder | 0.003800186 | 14 | 0 | BeFree |
Atypical Lipoma | 0.003800186 | 14 | 0 | BeFree |
Uterine Corpus Cancer | 0.003800186 | 14 | 3 | BeFree |
Esophageal Neoplasms | 0.003724241 | 6 | 0 | BeFree_GAD |
Diffuse Large B-Cell Lymphoma | 0.003724241 | 6 | 0 | BeFree_GAD |
ovarian neoplasm | 0.003724241 | 6 | 0 | BeFree_GAD |
Leukoplakia | 0.003452799 | 4 | 0 | BeFree_GAD |
Meningioma | 0.003452799 | 5 | 0 | BeFree_GAD |
Adenocarcinoma of pancreas | 0.003452799 | 4 | 0 | BeFree_GAD |
Malignant neoplasm of liver | 0.003452799 | 5 | 0 | BeFree_GAD |
Hepatitis C, Chronic | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Nasopharyngeal carcinoma | 0.003257302 | 12 | 7 | BeFree |
Carcinosarcoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Colonic Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Epilepsy, Temporal Lobe | 0.002995792 | 1 | 0 | BeFree_LHGDN |
synovial sarcoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Rhabdomyosarcoma, Embryonal | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Verrucous carcinoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Angiofibroma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Acute lymphocytic leukemia | 0.002985861 | 11 | 0 | BeFree |
Pancreatic carcinoma | 0.002985861 | 11 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.002985861 | 11 | 1 | BeFree |
Myeloid Leukemia, Chronic | 0.002909916 | 3 | 1 | BeFree_GAD |
oligodendroglioma | 0.002909916 | 3 | 0 | BeFree_GAD |
Cancer of Nasopharynx | 0.002909916 | 3 | 0 | BeFree_GAD |
Hepatitis B, Chronic | 0.002909916 | 2 | 2 | BeFree_GAD |
Epithelial ovarian cancer | 0.002909916 | 3 | 0 | BeFree_GAD |
Cessation of life | 0.00272435 | 1 | 0 | LHGDN |
Salivary Gland Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Infection | 0.00272435 | 1 | 0 | LHGDN |
Malignant Fibrous Histiocytoma | 0.002714419 | 10 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.002714419 | 10 | 0 | BeFree |
Crohn Disease | 0.002638474 | 1 | 0 | BeFree_GAD |
Cervical Intraepithelial Neoplasia | 0.002638474 | 2 | 0 | BeFree_GAD |
Sepsis | 0.002638474 | 1 | 0 | BeFree_GAD |
Malignant tumor of colon | 0.002442977 | 9 | 0 | BeFree |
Malignant tumor of cervix | 0.002442977 | 9 | 0 | BeFree |
Leukemia, Lymphocytic, Acute, L1 | 0.002442977 | 9 | 2 | BeFree |
Cervix carcinoma | 0.002442977 | 9 | 0 | BeFree |
Colon Carcinoma | 0.002442977 | 9 | 0 | BeFree |
Lipomatosis, Multiple | 0.002442977 | 9 | 0 | BeFree |
Spontaneous abortion | 0.002367032 | 1 | 0 | GAD |
Anoxia | 0.002367032 | 1 | 0 | GAD |
Cocarcinogenesis | 0.002367032 | 1 | 0 | GAD |
DNA Damage | 0.002367032 | 1 | 0 | GAD |
Fibrosis | 0.002367032 | 1 | 0 | GAD |
Hepatitis, Viral, Human | 0.002367032 | 1 | 0 | GAD |
Kidney Neoplasm | 0.002367032 | 1 | 0 | GAD |
Laryngeal neoplasm | 0.002367032 | 1 | 0 | GAD |
Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
Lymphatic Metastasis | 0.002367032 | 1 | 0 | GAD |
Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
Acoustic Neuroma | 0.002367032 | 1 | 0 | GAD |
Occupational Diseases | 0.002367032 | 1 | 0 | GAD |
Pharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Helicobacter Infections | 0.002367032 | 1 | 0 | GAD |
Choroid Plexus Neoplasms | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Second Primary | 0.002367032 | 1 | 0 | GAD |
Malignant neoplasm of brain | 0.002367032 | 1 | 0 | GAD |
Choroid Plexus Papilloma | 0.002367032 | 1 | 0 | GAD |
Restenosis | 0.002367032 | 1 | 0 | GAD |
Retinal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Pregnancy loss | 0.002367032 | 1 | 0 | GAD |
Carcinoma, Pancreatic Ductal | 0.002367032 | 1 | 0 | GAD |
Granulomatosis with polyangiitis | 0.002367032 | 1 | 0 | GAD |
Multiple Myeloma | 0.002171535 | 8 | 0 | BeFree |
Soft Tissue Neoplasms | 0.002171535 | 8 | 0 | BeFree |
Leukemogenesis | 0.002171535 | 8 | 0 | BeFree |
Glioblastoma Multiforme | 0.002171535 | 8 | 0 | BeFree |
Ichthyosis, X-Linked | 0.001900093 | 7 | 0 | BeFree |
Esophageal carcinoma | 0.001900093 | 7 | 0 | BeFree |
Medulloblastoma | 0.001628651 | 6 | 0 | BeFree |
Liposarcoma, Pleomorphic | 0.001628651 | 6 | 0 | BeFree |
Germ cell tumor | 0.001628651 | 6 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.001628651 | 6 | 5 | BeFree |
Solid tumour | 0.001628651 | 6 | 0 | BeFree |
Malignant Glioma | 0.001628651 | 6 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.001628651 | 6 | 0 | BeFree |
Bone neoplasms | 0.001357209 | 5 | 6 | BeFree |
Kidney Failure, Acute | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of mouth | 0.001357209 | 5 | 5 | BeFree |
Acute respiratory failure | 0.001357209 | 5 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.001357209 | 5 | 0 | BeFree |
Ataxia Telangiectasia | 0.001085767 | 4 | 0 | BeFree |
Choriocarcinoma | 0.001085767 | 4 | 0 | BeFree |
Hemangiosarcoma | 0.001085767 | 4 | 0 | BeFree |
Hepatitis B | 0.001085767 | 4 | 2 | BeFree |
Liver Cirrhosis | 0.001085767 | 4 | 0 | BeFree |
Cutaneous Melanoma | 0.001085767 | 4 | 2 | BeFree |
Adenocarcinoma of lung (disorder) | 0.001085767 | 4 | 0 | BeFree |
childhood rhabdomyosarcoma | 0.001085767 | 4 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.001085767 | 4 | 0 | BeFree |
Adenocarcinoma Of Esophagus | 0.001085767 | 4 | 2 | BeFree |
Anaplastic astrocytoma | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of kidney | 0.001085767 | 4 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.001085767 | 4 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.001085767 | 4 | 0 | BeFree |
Renal carcinoma | 0.001085767 | 4 | 0 | BeFree |
Tumor Angiogenesis | 0.001085767 | 4 | 0 | BeFree |
Ameloblastoma | 0.000814326 | 3 | 0 | BeFree |
Anaplasia | 0.000814326 | 3 | 0 | BeFree |
Astrocytoma | 0.000814326 | 3 | 0 | BeFree |
Blast Phase | 0.000814326 | 3 | 2 | BeFree |
Burkitt Lymphoma | 0.000814326 | 3 | 0 | BeFree |
Bronchogenic Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Chondrosarcoma | 0.000814326 | 3 | 0 | BeFree |
Fibroid Tumor | 0.000814326 | 3 | 0 | BeFree |
Mesothelioma | 0.000814326 | 3 | 0 | BeFree |
Uterine Fibroids | 0.000814326 | 3 | 0 | BeFree |
Virus Diseases | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of testis | 0.000814326 | 3 | 0 | BeFree |
Pleomorphic Lipoma | 0.000814326 | 3 | 0 | BeFree |
Lipomatous neoplasm | 0.000814326 | 3 | 0 | BeFree |
Embryonal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Cancer of Head and Neck | 0.000814326 | 3 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Carcinoma ex pleomorphic adenoma | 0.000814326 | 3 | 0 | BeFree |
Intrahepatic Cholangiocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Malignant mesothelioma | 0.000814326 | 3 | 0 | BeFree |
Breast Cancer, Familial | 0.000814326 | 3 | 0 | BeFree |
Skin carcinoma | 0.000814326 | 3 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.000814326 | 3 | 0 | BeFree |
Helicobacter pylori infection | 0.000814326 | 3 | 0 | BeFree |
Intimal sarcoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of skin | 0.000542884 | 2 | 0 | BeFree |
Mucinous Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma, Papillary | 0.000542884 | 2 | 0 | BeFree |
Congenital chromosomal disease | 0.000542884 | 2 | 0 | BeFree |
Ulcerative Colitis | 0.000542884 | 2 | 0 | BeFree |
Phyllodes Tumor | 0.000542884 | 2 | 0 | BeFree |
Ependymoma | 0.000542884 | 2 | 0 | BeFree |
Giant Cell Tumors | 0.000542884 | 2 | 0 | BeFree |
Adult T-Cell Lymphoma/Leukemia | 0.000542884 | 2 | 0 | BeFree |
Leukopenia | 0.000542884 | 2 | 3 | BeFree |
Neurofibromatosis 2 | 0.000542884 | 2 | 0 | BeFree |
Neutropenia | 0.000542884 | 2 | 3 | BeFree |
Odontogenic Tumors | 0.000542884 | 2 | 0 | BeFree |
Polycythemia Vera | 0.000542884 | 2 | 0 | BeFree |
Seizures | 0.000542884 | 2 | 0 | BeFree |
Benign Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of nasopharynx | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
Cholangiocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Adult Acute Myeloblastic Leukemia | 0.000542884 | 2 | 0 | BeFree |
pediatric acute myeloblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
Uveal melanoma | 0.000542884 | 2 | 0 | BeFree |
Medullary carcinoma of thyroid | 0.000542884 | 2 | 0 | BeFree |
Disseminated neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
Laryngeal Squamous Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Tumor necrosis | 0.000542884 | 2 | 0 | BeFree |
Adenoameloblastoma | 0.000542884 | 2 | 0 | BeFree |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
Nijmegen Breakage Syndrome | 0.000542884 | 2 | 0 | BeFree |
Trisomy 12 | 0.000542884 | 2 | 0 | BeFree |
Thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
Ewings sarcoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of larynx | 0.000542884 | 2 | 0 | BeFree |
Well Differentiated Oligodendroglioma | 0.000542884 | 2 | 0 | BeFree |
Familial Retinoblastoma | 0.000542884 | 2 | 0 | BeFree |
Malignant Squamous Cell Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Invasive breast carcinoma | 0.000542884 | 2 | 0 | BeFree |
Testicular malignant germ cell tumor | 0.000542884 | 2 | 0 | BeFree |
Invasive Ductal Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Childhood Leukemia | 0.000542884 | 2 | 0 | BeFree |
Hereditary Malignant Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Hepatitis B Virus-Related Hepatocellular Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Hepatocarcinogenesis | 0.000542884 | 2 | 0 | BeFree |
Cancer Cell Growth | 0.000542884 | 2 | 0 | BeFree |
Tumor Promotion | 0.000542884 | 2 | 0 | BeFree |
Xenograft Model | 0.000542884 | 2 | 0 | BeFree |
Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.000542884 | 2 | 2 | BeFree |
Abdominal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Adenovirus Infections | 0.000271442 | 1 | 0 | BeFree |
Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
Congenital arteriovenous malformation | 0.000271442 | 1 | 0 | BeFree |
Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
Tooth Attrition | 0.000271442 | 1 | 0 | BeFree |
Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of larynx | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
Adenoid Cystic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mental Depression | 0.000271442 | 1 | 0 | BeFree |
Depressive disorder | 0.000271442 | 1 | 0 | BeFree |
Breast Fibrocystic Disease | 0.000271442 | 1 | 0 | BeFree |
Fibrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Gastritis, Atrophic | 0.000271442 | 1 | 0 | BeFree |
Gastroesophageal reflux disease | 0.000271442 | 1 | 2 | BeFree |
Hamartoma | 0.000271442 | 1 | 0 | BeFree |
hemangiopericytoma | 0.000271442 | 1 | 0 | BeFree |
Hemochromatosis | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Hypertension | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Plasma Cell | 0.000271442 | 1 | 0 | BeFree |
Liver Cirrhosis, Alcoholic | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
Lymphoproliferative Disorders | 0.000271442 | 1 | 0 | BeFree |
Myoepithelioma | 0.000271442 | 1 | 0 | BeFree |
Neoplasms, Connective Tissue | 0.000271442 | 1 | 0 | BeFree |
Neurilemmoma | 0.000271442 | 1 | 0 | BeFree |
Nevus | 0.000271442 | 1 | 0 | BeFree |
Melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
Papilloma | 0.000271442 | 1 | 0 | BeFree |
Parathyroid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
polyps | 0.000271442 | 1 | 0 | BeFree |
Retinal Detachment | 0.000271442 | 1 | 0 | BeFree |
Kaposi Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Seminoma | 0.000271442 | 1 | 0 | BeFree |
Sezary Syndrome | 0.000271442 | 1 | 0 | BeFree |
Synovitis | 0.000271442 | 1 | 0 | BeFree |
Giant Cell Arteritis | 0.000271442 | 1 | 0 | BeFree |
Thrombocythemia, Essential | 0.000271442 | 1 | 0 | BeFree |
Vitiligo | 0.000271442 | 1 | 0 | BeFree |
Common wart | 0.000271442 | 1 | 0 | BeFree |
Xeroderma Pigmentosum | 0.000271442 | 1 | 0 | BeFree |
Low Grade Lymphoma (neoplasm) | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Pancreatitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
Epstein-Barr Virus Infections | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of oropharynx | 0.000271442 | 1 | 0 | BeFree |
Sarcoma, Spindle Cell | 0.000271442 | 1 | 0 | BeFree |
Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
Mixed Tumor, Mullerian | 0.000271442 | 1 | 0 | BeFree |
Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
Parosteal Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma, Clear Cell | 0.000271442 | 1 | 0 | BeFree |
Medullary carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mucoepidermoid Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Neoplasms, Neuroepithelial | 0.000271442 | 1 | 0 | BeFree |
Ganglioneuroblastoma | 0.000271442 | 1 | 0 | BeFree |
gliosarcoma | 0.000271442 | 1 | 0 | BeFree |
Nerve Sheath Tumors | 0.000271442 | 1 | 0 | BeFree |
adult soft tissue sarcoma | 0.000271442 | 1 | 0 | BeFree |
Papillary thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mucosa-Associated Lymphoid Tissue Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Proliferative vitreoretinopathy | 0.000271442 | 1 | 0 | BeFree |
Multiple tumors | 0.000271442 | 1 | 3 | BeFree |
Retractile Mesenteritis | 0.000271442 | 1 | 0 | BeFree |
Disorder of lymph node | 0.000271442 | 1 | 0 | BeFree |
Carcinoma breast stage IV | 0.000271442 | 1 | 0 | BeFree |
Metastatic osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
recurrent childhood acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Medulloblastoma, Adult | 0.000271442 | 1 | 0 | BeFree |
Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
stage, non-small cell lung cancer | 0.000271442 | 1 | 0 | BeFree |
stage, ovarian epithelial cancer | 0.000271442 | 1 | 0 | BeFree |
Leiomyosarcoma of uterus | 0.000271442 | 1 | 0 | BeFree |
Inflammatory Myofibroblastic Tumor | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma, intestinal type | 0.000271442 | 1 | 0 | BeFree |
Spindle cell lipoma | 0.000271442 | 1 | 0 | BeFree |
Anaplastic Oligodendroglioma | 0.000271442 | 1 | 0 | BeFree |
Human papilloma virus infection | 0.000271442 | 1 | 0 | BeFree |
Benign tumor of salivary gland | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of anal margin | 0.000271442 | 1 | 0 | BeFree |
Hematologic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Dermatofibrosarcoma Protuberans | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
Malignant tumor of eye | 0.000271442 | 1 | 0 | BeFree |
Benign neurologic neoplasms | 0.000271442 | 1 | 0 | BeFree |
Chronic active hepatitis | 0.000271442 | 1 | 0 | BeFree |
Sleep Apnea, Obstructive | 0.000271442 | 1 | 0 | BeFree |
Granulomatosis | 0.000271442 | 1 | 0 | BeFree |
Composite Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Progressive Neoplastic Disease | 0.000271442 | 1 | 0 | BeFree |
Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000271442 | 1 | 0 | BeFree |
Malignant fibrous histiocytoma of bone | 0.000271442 | 1 | 0 | BeFree |
Febrile Neutropenia | 0.000271442 | 1 | 2 | BeFree |
early pregnancy | 0.000271442 | 1 | 0 | BeFree |
Arnold-Chiari Malformation, Type I | 0.000271442 | 1 | 0 | BeFree |
Brain Tumor, Primary | 0.000271442 | 1 | 0 | BeFree |
Localized Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Pancreatic carcinoma resectable | 0.000271442 | 1 | 0 | BeFree |
Retinoblastoma unilateral | 0.000271442 | 1 | 0 | BeFree |
Undifferentiated (Embryonal) Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Breast adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
precancerous lesions | 0.000271442 | 1 | 0 | BeFree |
Salivary gland carcinoma | 0.000271442 | 1 | 0 | BeFree |
Endometrial adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Spindle cell rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Intratubular malignant germ cells | 0.000271442 | 1 | 0 | BeFree |
Spindle cell liposarcoma | 0.000271442 | 1 | 0 | BeFree |
Primary Effusion Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
Classical Hodgkin's Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Desmoplastic melanoma | 0.000271442 | 1 | 0 | BeFree |
Gastric Cardia Adenocarcinoma | 0.000271442 | 1 | 2 | BeFree |
Gastric Cardia Carcinoma | 0.000271442 | 1 | 2 | BeFree |
Hereditary Nonpolyposis Colorectal Cancer | 0.000271442 | 1 | 0 | BeFree |
Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Inflammatory malignant fibrous histiocytoma | 0.000271442 | 1 | 0 | BeFree |
Invasive Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Localized Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Oligodendroglial Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Treatment related acute myeloid leukaemia | 0.000271442 | 1 | 2 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Marginal Zone B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Periosteal Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Anal squamous cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Familial Idiopathic | 0.000271442 | 1 | 0 | BeFree |
Benign melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
Breast Cancer Model | 0.000271442 | 1 | 0 | BeFree |
Mammary Tumorigenesis | 0.000271442 | 1 | 0 | BeFree |
Poorly Differentiated Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Ganglioneuroblastoma, Nodular | 0.000271442 | 1 | 0 | BeFree |
Malignant Conversion | 0.000271442 | 1 | 0 | BeFree |
Salivary Gland Pleomorphic Adenoma | 0.000271442 | 1 | 0 | BeFree |
Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000271442 | 1 | 0 | BeFree |
tumor vasculature | 0.000271442 | 1 | 0 | BeFree |
Enchondroma | 0.000271442 | 1 | 0 | BeFree |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.000271442 | 1 | 0 | BeFree |
Urothelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Oropharyngeal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Pancreatic carcinoma, familial | 0.000271442 | 1 | 0 | BeFree |
Progressive cGVHD | 0.000271442 | 1 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Fibromyxosarcoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。